First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted 212 Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine · 2025
DOI: 10.2967/jnumed.124.269299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Kjetil Berner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Antigens, Surface, Glutamate Carboxypeptidase II, Lead Radioisotopes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Oslo University Hospital, Oslo, Norway.
- Department of Nuclear Medicine, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Intervention Centre, Oslo University Hospital, Oslo, Norway.
- Department of Physics, University of Oslo, Oslo, Norway.
Zitieren
APA
Berner, K., Hernes, E., Kvassheim, M., Revheim, M. E., Bastiansen, J., Selboe, S., Bakken, C. L., Grønningsæter, S. R., Bruland, Ø. S., Larsen, R. H., Bouzelmat, L., Jardine, V. L., & Stokke, C. (2025). First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted 212 Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.269299
Vancouver
Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, et al. First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted 212 Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.269299
BibTeX
@article{Berner2025,
author = {Berner, Kjetil and Hernes, Eivor and Kvassheim, Monika and Revheim, Mona-Elisabeth and Bastiansen, Julie and Selboe, Silje and Bakken, Charlotte L and Grønningsæter, Simen R and Bruland, Øyvind S and Larsen, Roy H and Bouzelmat, Lily and Jardine, Vicki L and Stokke, Caroline},
title = {First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted 212 Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer},
journal = {Journal of Nuclear Medicine},
year = {2025},
doi = {10.2967/jnumed.124.269299}
}
EUVIMED